About this episode

The episode discusses the DOJ's brief against marijuana rescheduling and the implications for public health and the pharmaceutical industry.

Send us Fan Mail DOJ just filed a brief telling the D.C. Circuit to deny the anti-rescheduling stay motion — and the argument is brutal: the drug-testing lobby and cannabinoid pharma challengers are not protecting public health, they are protecting “pocketbook interests.” This week on Cannabis Legalization News, Tom and Miggy break down the DOJ’s new marijuana rescheduling brief, the live DEA hearing where the government is now arguing FOR Schedule III, Illinois’ new SB 3222 cannabis and hem...

People in this episode

Hosts: Tom, Miggy

Topics covered

• marijuana rescheduling
• drug policy
• cannabis legislation
• public health
• pharmaceutical industry

Keywords

• marijuana
• rescheduling
• DOJ
• DEA
• Illinois cannabis law

Mentioned in this episode

Organizations: DOJ, DEA

Books & works: SB 3222

Places: Illinois

More episodes of Cannabis Legalization News Podcast

• DEA Rescheduling Hearing Wraps, 280E Refund Fight, and Cannabis Legalization News Roundup · July 19, 2026 · 58 min
• The Cannabis Battle Intensifying on Every Front | Virginia, DEA & Massachusetts · July 13, 2026 · 57 min
• DEA Stacks Hearing Against Cannabis Industry—Here's What Happens Next · June 28, 2026 · 43 min
• Supreme Court Gun Rights, DEA Rescheduling Hearing, and Dispensary Updates · June 20, 2026 · 41 min
• Drug Testing Lobby Sues Over Schedule III as Illinois Signs Major Cannabis Law Changes · June 14, 2026 · 39 min

Explore listener stats, chart rankings, contacts and more on the Cannabis Legalization News Podcast podcast page.